Clinical Trial Update: Immunoparalysis After Pancreaticoduodenectomy

View source ↗

Summary

An ongoing clinical trial in Lyon is recruiting to study immunoparalysis after pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma, includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma
• Pancreatic Fistula

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Pancreatic Ductal Adenocarcinoma (mPDAC), Pancreatic Head Tumour | Status: RECRUITING